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Among 391 consecutive patient ; admitted for acute myocardial
infamion and treated with thrombulytne drugs, 4 patients (1%)
developed an early hemorrhagic pericardial effusion (without
ventricular wall rupture) evolving within 24 h to cardiogenic
shock consequent to cardiac tameronade . They all suffered from a
large anterior myocardial infamion treated wilhet 4 hatter cowl
of symptoms with intravenous anisoylated plasminogen streptoki-
Anse activator complex lone case), reeombiant dssueaype plan •
minogen activator (rt-PA) (two cases) or streptokinase (one ease),
anticoagulation with heparin (all cases) and aspirin (three cases) .
As soon as pericardial effusion was established by eehocardiug-
Many large controlled trials 11-8) have demonstrated that
thrombolysis performed during the first hours after the onset
of symptoms in patients with acme myocardial infarction
decreases infarct site, limits left ventricular dysfunction and
reduce : hospital mortality irrespective of the type of throm-
bolytic agent used . Accordingly, the rate of the most com-
mon infarct-related complications has been favorably af .
fected by thrombolysis . Hemorrhage is the major specific
side effect of thrombolytic agents (9-11). With an incidence
of <We in most reported studies, cerebral hemorrhage
represents the most serious bleeding . On the other hand .
pericardial bleeding (primary hemopericardium) represents a
well-known complication of chronic anticoagulation hut was
very uncommonly reported as an early complication after
thrnmbotytic therapy for n cute myocardial infarction except
in case at rupture (secondary hemopericardium) .
We report the clinical, hemadynamic and angiographic
data of four patients who presented with cardiac lamponade
due to pericardial hemorrhage during the first 24 h after
intravenous thrombolysis for acute myocardial infarction in
the absence of ventricular wall rupture .
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raphy, emergency pereutaneous pericardiocentesis was performed
at the bedside 20 t 6 h after thrombolytic therapy was started .
This corrected Immediately the clinical and henodynamic status
of each patient and a catheter was left in the pericardial space for
34 a 1S h
. Thus, in The presence of aneaplained clinical and
hemudynamie deterioration occurring during the first 01 h after
thromholytie treatment or a large myocardial infarction, cardiac
tamponade should be suspected . €mmediate percutaneous pericar.
diocenlesis followed by continuous drainage is a simple and
definitive treatment for this eompliealimt.
(J
Am Cod Cardiol
1991,17
.280-5)
Methods
Study patients . We reviewed the clinical records of 392
consecutive patients admitted to the coronary care unit
between 1984 and June 1989 for acute myocardial infarction
and treated with various thrombolytic drugs. We excluded
from this study three cases of hemopericardium observed
after thrombolysis for myocardial infarction
. One occurred
at pacemrker removal 2 days after thrombolysis and was
obviously related to a right ventricular perforation . The two
remaining cases were observed late after ihromholysis, 16
and 15 days respectively, in patients treated with oral
anticoagulants. Successful pericardiocentesis was per-
formed in each case.
Treatment protocol. Different thrombolysis protocols
were applied to these patients : 250,000 IU strentokinase
intracoronary (n = 42), 500,00(1 IU streptokinase intrave-
nously (n = 249), 1 .500,000 IU streptokinase intravenously
(n 40), 30 mg anisoylated plasminogen streptokinase
activator complex (APSAC) intravenously (n = 11) and
100 mg recombinant tissue-type plasminogen activator
(rt-PA) intravenously to - 50)
.
Detailed protocols have been
previously published using streptokinase (II), APSAC
(11 .12) or rt-PA (4,13) . All patients were given heparin
before and during thrombolysis (intravenous bolus of 5 .0(10
to IC 000 IU) followed by an infusion of 600 to 1 .200 IU per
h fur 3 to 4 days . Concomitant therapy was usually limited to
analgesics and nitroglycerin or isosorbide dinitrate infusions .
In case streptokinase or APSAC was given . treatment with
aspirin (I0o to 300 nag per day orally) was started after
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Table
1 .
Clinical No
. in Four Patients
I
Age Iyrl
	
60
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MIlocalien ANT
'fine delay Crew symptom 145
pmrt to rhrumbrdysm lmlnl
tv T0rombolytic egret used AP.AC
1n gel
Conr•5mitanlhernpy IV HEY
IV ASA
Time delay from symptom 5.5
onset m peak CK 1h1
Peak CK (1 Glilerl 2J N)
heparin infusion was discontinued . For patients treated with
rt-PA, aspirin therapy was stand nn admission .
Patient monitoring. In the coronary care unit all patients
were continuously monitored by electrocardiogram IECGI
and invasive arterial pressure measurements during 3 to
4 days. Right heart catheterization was performed when
clinically indicated in case of extensive infarction or
heart failure . Serial creatine kinase iCKI determinalions
(normal <160 IU) were performed every 3 h during the
first 24 h and every 6 h during the next 2 days . Echocardi-
ography (ADR 4,000 S-LC unit with a medium focus
3 MHz transducer) was available 24 h a day but was
not routinely recorded on admission except for specific
clinical reasons . Coagulation
studies
were Performed in
some subgroups of patients, as reported in derail elsewhere
1111 .
Diagnosis and treatment of cardiac ramponade . The diag-
nosis of cardiac tampunade was made in the presence of the
following criteria : 1) new and unexplained development of
clinical signs of shock : hypotension, tachycardia and poor
peripheral perfusion ; 21 hemodynamic data compntible with
lampanade ; diastolic elevation and equalization of right
alrial (>10 mm Hg). pulmonary artery and pulmonary cap-
illary wedge pressures; 31 presence of a paradoxical pulse
exceeding 10% of the systolic pressure during normal respi-
ration ; and 41 echocardiogr phic evidence of pericardial
effusion .
For pericardiocentesis after local anesthesia, a
.I gauge
needle was advanced in the suhxiphoid space directed
toward the left midclavide under pressure control . Once
blood could be withdrawn . recording the inlrapericardial
pressure insured the proper location of the needle . Then a
0.024 in . and 30 cm lung
guide-ire
was inserted and a 20 cm
long 4 F catheter ISeidicath . Plastimed, France) was ad-
vanced by the Seldinger technique and left in the pericardial
space .
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Case Reports
Among the 392 patients with acute myocardial infarction
treated by thrombolysis . 4 patients (191 developed a docu-
mented hemorrhagic pericardial effusion, evolving in <24 h
to a clinical and hanodynamie syndrome of cardiac tampon-
ade .
Clinicai and hemudynaric data (Tables 1 and 2). All four
patients were X60 years old and were admitted while devel-
oping a tar-Re anterior myocardial infarction . The mean time
delay between onset of symptoms and thrombolysis was 215
{ 59 min. Tamponade occurred with each of the three
lhrombolytic compounds used. Early serum CK peaking
after symptom onset (9
'-
2.5 h) was consistent with a
successful reperfusion in each case . Excessively high peak
CK levels were observed in Patients 2.3 and 41>5.500 RUl
suggesting a large infarct size .
Heart rate and arterial systolic and diastolic pressures
were normal at the beginning of the thrombolylic infusion
(
Fig
. 1)
. Chest pain was present at the initiation of treatment
and disappeared to decreased significantly during or after
thrombolytic thempy. Only Patient 4 had no real impmve-
Table 2. Characteristics of the Pericardial Effusion in
Four Patients
OATH = intrayericardul catheln : P.P. = pericardial
pundarc.
Petem
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Figure 1, Hemodynamic pattern (mean values x 15D) during the
first 4 days after admission and thrembnlysis in four patients with
cardiac lamponade. Square = heart rate (beatslmin) : circle =
systolic blood pressure (mm Fig) : Triangle = diastolic blood pressure
(mm Hg) : ADM = an admission : P .P. = pericardial puncture.
ment of her chest pain immediately after thrombolysis .
Patient 3 complained of reappearance of chest discomfort
12 h after thrombolysis and this was associated with the
presence of a typical pericardial friction rub .
After a time delay of 14 ± 6 0, we observed in each case
a progressive, but significant, hemodynamic deterioration .
The clinical syndrome was characterized by tachycardia,
hypotension, tachypnea and signs
of serious reduction of
peripheral perfusion suggestive of cardiogenic shock
. Hemo-
dynamic data were compatible with cardiac tamponade and
echocardiography confirmed in each case the presence of a
significant pericardial effusion . Emergency pericardiocente
.
sin was successfully performed at the bedside in the four
cases
. In Patient 3 respiratory arrest required the use of
endotracheal imubation s
imultaneou .ly with pericardial
puncture and mechanical ventilation during 4 h . The mean
time delay between thrombolysis and puncture was 20 m 6 h .
The mean intrapericardial pressure was 14 ± 3 mm Hg
TaUr 3 . Coagulation Data in Four Patients
(Table 2) . After rapid removal of about 100 ml of pericardial
blood, a dramatic clinical and hemodyramic improvement
was observed and maintained in each patient. The: intmperi-
cardial catheter was left in place for continuous drainage
during'34 -
18 h and the mean volume removed during this
period was 421 a 126 ml .
Twenty four hours after the pericardial drainage the
clinical status of each patient remained significantly im-
proved, as confirmed by hemodynamic data that had re-
turned to baseline values (Fig . I)
. Nevertheless, each patient
suffered from pericardial chest pain during 12 to 24 h after
pericardial fluid removal associated with a typical pericardial
rub. Echocardiograms were performed daily during 4 days
and confirmed the disappearance of pericardial effusion . No
other major complication occurred and patients were dis-
missed from the coronary care unit after 7 a 3 days .
Coagulation data (Table 3) . Baseline values of fibrinogen
and thrombin clotting time were within the normal range
before treatment. The fibrinogen level was significantly
depressed during the first 12 h after APSAC infusion as
opposed to ri-PA infusion where a <50% decrease was
observed
. In each case the thrombin time was highly pro-
longed (>l20 s) as a consequence of full heparinization
before cardiac lampanade and pericardial puncture . At that
time heparin was stopped and neutralized using protamine
sulfate in two patients . No plasmin inhibitors were given . In
Patient 4 low-dose heparin was started again after pericardial
puncture, which explains the persistent prolonged thrombin
time.
Angiugraphic data (Table
4).
In Patients I and 2 early
coronary patency was confirmed by angiography 5 and 2 h,
respectively, after thrombolysis and for Patient 2 immediate
coronary atlgitsnlasty was successfully performed on the
infarct-related stenosis located in the proximal left anterior
descending artery
. These procedures were part of specific
protocols (12,13).
Angiographic evaluation was performed after a few days
for Patient 3 (11 days) and Patient 4 (3 days)
. The absence of
high-grade residual stenosis in the left anterior descending
artery was noted in each patient, The residual stenosis was
'Time interval during which pericardial puncture was performed (between
12 and 24 h in Patients 1, 2 and 4 and
between 24 and 48 h
in Patient 3). Fg = fibrinogen Tmgl lm ml: normal range 150 to 3501: NA =
not available ; Tr =
thrombin lime (seconds ; normal range 18 to 22) .
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I Fit 230
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>120 33 21
2
Fit 280 170 175 230 3551
Tr
21 >120 u-120 38 14
3 Fit
224 167 210 337 '
539
TT 26 120 120 120 23
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NA NA 244 NA 387
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Tabk 4. Angiographic Data in Four Patients
'aloft
Time delay between
lhramholysis and
aagiugraphy
Infarct-rela'ed
vessel
LAD residual
stenosis 3%)
Number ofdiscated
vessels ('s0%)
Fjeotion frie ier
1%)
'Immediate and successful angioplasty was performed immediately ally,
diagnostic coronary angiography . LAD = left anterior descending artery .
estimated as 50% to 75% in luminat diameter in Patient I
(three-vessel disease) and Patient 2 (one-vessel disease
treated by angioplasty) . In patients 3 and 4 the residual
stenosis was estimated as <50%, so that no significant
coronary stenosis could be demonstrated in these patients .
However, severe left ventricular dysfunction was observed
in each case confirming the extensive myocardial damage in
spite of reperfusion . Anterior systolic dyskinesis was
present except in patient 2 in whom only anterior akinesis
was observed .
Follow-up data, Patients 1 . 2 and 4 had an uneventful
in-hospital evolution after the CCU period . They performed
a maximal bicycle exercise test associated with thallium 201
scintigraphy at a mean of 14 ± 4 days after admission . In
each case there were no clinical or ECG signs of myocardial
ischemia . Thallium scintigraphy showed a large nonrevers-
ible anterior perfusion defect in each case . After a mean
follow-up of 33 months (range 5 to 54), these three patients
were alive and free of cardia^ symptoms .
In patient 3 subacute myocardial rupture was suspected
because he showed the most severe left ventricular dysfunc-
tion with extensive anterior dyskinesis. Therefore, aneurys-
mectomy was contemplated and performed 18 days after
admission . No macroscopic evidence of previous myocar .
dial rupture could be observed, as well as io abnormal
feature in the pericardial cavity . However, the patient died 3
days after the operation because of intractable ventricular
arrhythmias.
Discussion
Hemorrhage is the major specific side effect of throm-
bolytic therapy . According to the data of the major clinical
trials evaluating thrombolysis in acute myocardial infarction
(I-l0), the most severe complication is related to cerebral
hemorrhage with an incidence of O% to 1 . 77, usually occur-
ring within the first 48 h after treatment and with a mortality
rate of 20% to 50% . In our experience of 392 consecutive
RENKIN EF AL.
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patients treated with various thrombolytic agents, only one
fatal cerebral accident was observed (0 .3%). However,
during the same period we noted in four cases the rapid
development of hemopericardium with cardiac tamponade
occurring in the first hours after thrombolytic therapy .
Because these cases were not related to cardiac rupture and
secondary hemopericardium, this complication must be con-
sidered as a major primary hemorrhagic complication of
thrombolytic treatment associated with anticoagulation .
Early recognition of this life threatening complication al-
lowed proper treatment using pcrcuraneous pericardial
drainage .
Previous reports . In a large review by Yusuf et al . (14) of
33 earlier studies using intracoroaary or intravenous throm-
bolysis in acute myocardial infarction, no case of early
hemopericardium was Observed in >7,000 patients . Simi-
larly, no case of primary hemopericardium or cardiac tam-
ponade was documented in the major randomized clinical
trials (1-10). published since 1986, that used different throm-
bolytic drugs and included more than 23,000 patients,
To the best of our knowledge, only three cases of late
hemopericardium have been documented and reported
(15,16), all three cases occurring after intracoronary strep-
tokinase infusion. Surgical pericardial drainage was per-
formed several days after thrombolytic treatment (3rd, 91h
and 10th day, respectively) . However, in our patients an
emergency pericardiocentesis followed by prolonged contin-
uous catheter drainage was performed within the first 26 h
after intravenous thromholysis because of early cardiac
tamponade with cardiogenic shock.
Several reasons may explain the absence of similar
reports to date . The first one could he related to a clustering
phenomenon for this exceptional complication in our insti-
tution during this particular time period . On the other hand,
the diagnosis of tamponade may have been missed if hetno-
dynamic or echocardiographic monitoring, or both, were not
available or used . The clinical pattern of early and evolving
cardiogenic shock can be -regarded as infaret-related left
ventricular failure or as suhacute cardiac rupture . In addi
tion, even when the diagnosis of tamponade is suspected. the
physician may hesitate to perform pericardioeemesis in the
presence of coagulation defects- With these considerations
in m ind. it
s possible that some early deaths reported as
"cardiogeniC shock" or "suspected myocardial rupture" in
the different studies previously reported (1-10) could have
been related to unrecognized cardiac tamponade . This sus-
picion is reinforced by data from the Gissi trial (17) where a
surprising and unexplained excess of death was observed on
the first day in treated patients as compared with the placebo
group (31 .8% of the 628 versus 20 .2% of the 758 deaths,
respectively . that occurred during the let week) .
Pathophysiology . In the absence of cardiac rupture, some
cases of hemopericardium were reported before the throm-
bolysis era either as spontaneous complications or more
frequently associated with anticoagulant therapy after infarc-
2 3 4
5 h 2 h I I days 3 days
LAD LAD LAD LAD
III In 75 So 1 . 75 <5(1 <ID
3
(<,A)'
I(01' 0 0
34 44 29 43
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LionOP.S) These cases were reported as occurring a few days
after infarction but not during the first 24 h .
Pericardial bleeding is also observed in absence of myo-
cardial infarction in nonspecific pericarditis or during anti-
coagulation therapy (18,19)- Another case was reported (20)
after intravenous throreholytic treatment of acute pulmonary
embolism . Accordingly, the hypothesis hat could explain
the early cardiac tamponadc in our patients implies the
association of two triggering factors . The first is the occur-
rence of a large anterior transmittal infarction with an early
form of 'aericarditis, as clinically evidenced in one of our
patients . 1t is noteworthy that the three previously reported
cases (15,161 also involved a large anterior infarction . The
second factor is the major alteration in coagulation related to
the combination of thrombolytic agents, heparin and aspirin .
Such drug association is not unusual and was used in most
recent large scale trials ofthrombolysis in acute myocardial
infarction
In addition, the coagulation data demon-
strate that a profound systemic lyric state was not present in
our two patients treated with rt-PA . In this hypothesis the
drug regimen used to obtain sustained coronary recanaliza-
tion cannot, in itself, be the only triggering factor
. It is
surprising to note that in each of our patients coronary
angiography showed good patency of the infarct-related left
anterior descending artery without severe residual stenosis .
A relatively brisk myocardial reperfusion after prolonged
acute ischemia in a large area at risk can lead to an
hemorrhagic infarction, as demonstrated by experimental
studies (21,22). However, none of these studies reported the
association of hemorrhagic myocardial infarction and hemo-
pericardium, Similarly, a few postmortem studies (23-26)
documented myocardial hemorrha6Ac necrosis in patients
treated with intracoronary or intravenous thrombolysis but
no associated hemopericardium was reported . This suggests
the absence of a direct relation between early myocardial
rcperftksion and pericardial bleeding within the first 24 h .
Treatment, According to the unclear pathophysiology of
early hemupericardiam occurring within the first hours after
thrombolysis for myocardial infarction, optimal treatment-
percutaneous or surgical pericardial drainage-remains
questionable
. Some authors (27-29) have reported dramatic
clinical and hemedynamic improvement after pericnrdioeen-
tests performed for a documented (postmortem or postoper-
ative) subacute myocardial rupture, in some patients only a
temporary improvement was observed because a fatal rup-
ture eventually occurred
; in others this improvement al-
lowed a successful surgical repair of a subacute rupture .
However, no case of prolonged percutaneous pericardial
drainage without surgical intervention was reported,
In our four patients, because of their precarious clinical
status, immediate pericardiocentesis was performed and
continuous pericardial drainage maintained for more than
24 h, allowing the removal of
more than 300 ml in each case .
These blood volumes are comparable with those in previ-
ously reported cases (600, 450 and 400 ml) (15,16)
. This
technique appears more rapid and simple for acute patients
with evolving cardiac tamponade and cardiogenic shock, as
compared with emergency surgery . In addition, pericardia
eentesis allows the patient's condition to improve and stabi-
lize in case surgery should be eventually performed .
Conclusions. Early pericardial hemorrhage occurring af-
ter thrombolysis for acute myocardial infarction should be
considered as a major complication whose incidence may be
comparable with that
of cerebral hemorrhage . Therefore . in
the presence of unexplained clinical and hcmodynamic de-
terioration occurring during the first hours of thrombolytic
therapy of a large acute myocardial infarction, echocardio-
graphic examination must be rapidly performed to exclude
this potentially lethal, but tractable, complication, bedside
pericardiocentesis followed by prolonged pericardial drain-
age is a simple, immediate and safe treatment yieldinga good
prognosis . Early hemorrhagic pericarditis may occur during
the first hours after a large acute transmural myocardial
infarction in patients treated with anticoagulant, antiplateler
and thrombolytic agents.
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